Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LANTRONIX INCLTRX · Entity 1667 | Director · President & CEO | September 09, 2026 | September 09, 2026 |
| SIGMA DESIGNS INCSIGM · Entity 164293 | Director | February 25, 2018 | March 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LANTRONIX INC
Report date September 09, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 453,381 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Purchase · Acquired 15,000 · Balance 453,381 F1: This transaction was executed in multiple trades at prices ranging from $5.17 to $5.18. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $5.17 to $5.18. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
SIGMA DESIGNS INC
Report date February 25, 2018 · Filed March 06, 2018
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
Section 16 reporting ended · disclosed 2023-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,587 |
Ending reported balance
After 2023-11-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-17 · Grant · Acquired 772 · Balance 43,856 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Row 2 · 2023-11-17 · Tax withholding · Disposed 1,269 · Balance 42,587 F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2023 Filed Aug 21, 2023 22:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046810 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,065 F2 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020, and August 17, 2021. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 22:59 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 20,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046810 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,284 F1 · shares: Includes (i) 12,761 shares of which one-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2023, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2026, and (ii) 8,161 shares of which one-twelfth of the total number of restricted stock units shall vest each quarter following the vesting commencement date of August 17, 2023, until fully vested on August 17, 2026. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 22:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 7,669 | $91.16 | $699,125.21 |
DisclosureSEC source: 0001209191-23-046108 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,362 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.89 to $91.4050, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:00 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 606 | $81.02 | $49,098.12 |
DisclosureSEC source: 0001209191-23-031204 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,031 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:00 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031204 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,637 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2 · balance_after: Includes 110 shares acquired under the Issuer's employee stock purchase plan on March 15, 2023. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 21:04 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 5,000 | $115.28 | $576,402.00 |
DisclosureSEC source: 0001209191-23-018217 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,755 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.14 to $115.34, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 658 | $122.04 | $80,302.32 |
DisclosureSEC source: 0001209191-23-011732 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,755 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011732 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,413 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:53 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,000 | $102.80 | $411,200.00 |
DisclosureSEC source: 0001209191-22-060954 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,641 Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:51 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 605 | $100.27 | $60,663.35 |
DisclosureSEC source: 0001209191-22-058242 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,641 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:51 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058242 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,246 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 22:02 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,822 | $106.58 | $194,182.57 |
DisclosureSEC source: 0001209191-22-056655 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,474 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.525 to $106.63, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 6,421 | $88.60 | $568,900.60 |
DisclosureSEC source: 0001209191-22-055086 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,296 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:25 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 8,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055086 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,717 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on October 31, 2019. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 8,562 | $99.01 | $847,723.62 |
DisclosureSEC source: 0001209191-22-052461 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,539 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 22:07 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 16,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052461 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,101 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on October 31, 2019. F2 · balance_after: Includes 137 shares acquired under the Issuer's employee stock purchase plan on September 15, 2022. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,000 | $123.00 | $492,001.20 |
DisclosureSEC source: 0001209191-22-049746 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,608 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123 to $123.09, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 22:30 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 174 | $133.50 | $23,229.00 |
DisclosureSEC source: 0001209191-22-047755 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,608 Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 22:30 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 53 | $133.54 | $7,077.62 |
DisclosureSEC source: 0001209191-22-047755 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,782 Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 22:30 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,773 | $133.58 | $504,000.74 |
DisclosureSEC source: 0001209191-22-047755 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,835 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.50 to $133.76, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), and any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 9,283 | $138.12 | $1,282,167.96 |
DisclosureSEC source: 0001209191-22-046884 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,608 F4 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 13,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046884 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,891 F3 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020 and August 17, 2021. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 7,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046884 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,978 F1 · shares: One-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2022, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2025. F2 · balance_after: Includes 53 shares acquired under the Issuer's employee stock purchase plan on March 15, 2022. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 23:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,000 | $276.00 | $276,000.00 |
DisclosureSEC source: 0001209191-21-067026 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,844 Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 22:13 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 5,000 | $250.03 | $1,250,137.00 |
DisclosureSEC source: 0001209191-21-064514 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,844 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250 to $250.275, inclusive. The reporting person undertakes to provide to Synaptics Incorporated ("the Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 23:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,000 | $255.00 | $765,000.00 |
DisclosureSEC source: 0001209191-21-063939 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,844 Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 22:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 9,303 | $194.57 | $1,810,084.71 |
DisclosureSEC source: 0001209191-21-062496 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,844 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. Read SEC document |
| October 31, 2021 Filed Nov 2, 2021 22:44 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 8,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062496 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,147 F1 · shares: Reflects shares released in connection with the vesting of performance stock units granted on October 31, 2019. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:28 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 6,227 | $179.73 | $1,119,178.71 |
DisclosureSEC source: 0001209191-21-059084 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,967 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of market stock units. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:28 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 11,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059084 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,194 F1 · shares: Reflects shares released in connection with the vesting of market stock units granted on December 14, 2018 and October 31, 2019. F2 · balance_after: Includes 174 shares acquired under the Issuer's employee stock purchase plan on September 15, 2021. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,732 | $189.33 | $895,909.56 |
DisclosureSEC source: 0001209191-21-055042 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,123 Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:33 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 126 | $189.72 | $23,904.33 |
DisclosureSEC source: 0001209191-21-055042 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,855 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,249 | $167.74 | $880,467.26 |
DisclosureSEC source: 0001209191-21-052606 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,981 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units, market stock units, and restricted stock units. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 7,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052606 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,230 F2 · shares: Reflects shares released in connection with the vesting of performance stock units and market stock units granted on August 17, 2020. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 4,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052606 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,483 F1 · shares: One-third of the total number of restricted stock units shall vest on the first anniversary date following the vesting commencement date of August 17, 2021, and one-twelfth of the total number of restricted stock units shall vest each quarter thereafter until fully vested on August 17, 2024. Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 20:01 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,309 | $151.92 | $198,863.28 |
DisclosureSEC source: 0001209191-21-049264 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,854 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 22:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,581 | $135.66 | $214,478.46 |
DisclosureSEC source: 0001209191-21-038741 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,163 Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 1,427 | $139.87 | $199,594.49 |
DisclosureSEC source: 0001209191-21-029530 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,744 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. F2 · balance_after: Includes 126 shares acquired under the Issuer's employee stock purchase plan March 15, 2021. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 17:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,700 | $128.89 | $219,113.00 |
DisclosureSEC source: 0001209191-21-010639 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,045 Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 17:35 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,769 | $125.00 | $221,125.00 |
DisclosureSEC source: 0001209191-21-010639 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,745 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 00:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,294 | $122.00 | $157,868.00 |
DisclosureSEC source: 0001209191-21-009011 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,514 Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 00:15 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 500 | $122.04 | $61,020.00 |
DisclosureSEC source: 0001209191-21-009011 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,808 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 17:38 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 139 | $79.60 | $11,064.40 |
DisclosureSEC source: 0001209191-20-058987 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,308 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020, as amended by that certain First Amendment dated March 13, 2020. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 300 | $84.49 | $25,347.00 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 4 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,447 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.47 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,112 | $83.43 | $259,648.48 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,747 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.12 to $83.92, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,720 | $82.58 | $142,045.34 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,859 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.11 to $83.08, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:12 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,364 | $81.61 | $274,528.30 |
DisclosureSEC source: 0001209191-20-057775 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,579 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.10 to $82.09, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,023 | $76.67 | $385,113.41 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 3 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,943 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,231 | $76.67 | $401,060.77 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 2 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,966 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 9,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056720 · doc4.xml · nonDerivative · entry 1 Awsare Saleel · CIK 0001733464 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,197 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on December 13, 2017 and October 31, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.